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Cyclosporine (CsA),t an effective immunosuppressive agent, is important in the
treatment of several autoimmune diseases (1, 2) and the enhancement of graft sur-
vival (3-5), possibly facilitating the induction of transplantation tolerance. CsA in
vitro inhibits the proliferative response of a primary MLR and prevents the devel-
opment of cytotoxic T cells by interfering with the production of IL-2 and at higher
doses the upregulation of its receptor (6). Its immunobiological role in tolerance
induction, however, remains enigmatic. Although known as a potent suppressor of
acute allogeneic graft-versus-host disease (GVHD) (7), CsA elicits an extensive auto-
immune syndrome 14-21 d after the cessation oftherapy after syngeneic bone marrow
transplantation (8). This autoaggression syndrome is histologically indistinguish-
able from allogeneic GVHD. The occurrence ofCsA-induced autoimmunity in rats
autologously reconstituted from a shielded tibia reversed a landmark concept: no
longer is histocompatibility disparity a requirement for GVHD, as once postulated
by Billingham (9).
This autoimmune disease is mediated by T cells (10, 11) and is intimately associated
with the insurgence of OX8+ (CD8) autocytotoxic T lymphocytes, which appear
to recognize a public epitope on class II major histocompatibility antigens (12). A
W3/25+ (CD4) helper subset appears also to play an important role in this disease
(10). Previous studies have suggested that the requirements for the successful induc-
tion of syngeneic GVHD (SGVHD) include thymic irradiation and CsA treatment
(8, 10). In addition, evidence has been presented that suggests that a host resistance
mechanism must be eliminated before the development of this autoaggression syn-
drome (11).
In the present study we compare the specific requirements for the induction and
adoptive transfer of SGVHD, which are two experimental modalities reflecting un-
derlying processes fundamental to this complex autoimmune phenomenon. We re-
veal evidence that suggests that induction ofSGVHD and host resistance to the adoptive
transfer are two distinct mechanisms with different drug and radiation dose sensi-
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tivities. Host resistance to adoptive transfer is mediated by an autoregulatory popu-
lation that is thymic dependent, and sensitive to radiation and cyclophosphamide (CY).
Rats
Lewis (L,RT1) female rats, Corona virus free, and6-8 wks old, were purchased from Charles
River Breeding Laboratories (Wilmington, MA) and kept in isolation.
Radiation
Total Body Irradiation (TBI).
￿
Lewis rats were irradiated on day 0 with either 1050, 750,
500, or 300 rad at 108 rad/min from a dual-source 137C ,S small animal irradiator (Atomic
Energy of Canada Ltd., Kanata, Ontario, Canada).
Hemibody Irradiation.
￿
Lewis rats were irradiated in a'37Cs irradiator (J . L. Shepard Mark
I, Glendale, CA) with a collimated beam. The attenuated dose directed either at the thymus
or the pelvis was estimated to be 1,050 rad at 1 cm from the collimated beam without taking
into effect the radiation dose absorbed in that 1 cm of intervening tissue. On day 0 of trans-
plantation the rats received 50 x 106 splenocytes from autoimmune donors.
Other Preparative Regimens
Materials and Methods
CY
￿
Lewis rats were injected intraperitoneally with 200, 100, 50, or 25 mg/kg ofCY (Mead-
Johnson, Evansville, IN) on day -1 before either the administration of a 30-d regimen ofCsA
therapy or the adoptive transfer of effector splenocytes.
Busulfan.
￿
Lewis rats were gavaged with 30 mg/kg of Busulfan (Burroughs Wellcome) on
day 2 prior to the initiation of the induction of SGVHD or the adoptive transfer of effector
splenocytes.
CYand Busulfan.
￿
Lewis rats were gavaged with 30 mg/kg of Busulfan (Burroughs Well-
come Co., Greenville, NY) on day -2 and injected intraperitoneally with 200 mg/kg ofCY
on day -1 before the initiation on day 0 of bone marrow reconstitution and CsA therapy
for the induction phase.
Bone Marrow Transplantation
Donor viral-free Lewis rats were killed by C02 asphyxiation. Marrow was collected from
the femurs, tibia, and humeri in RPMI 1640. The marrow cells were adjusted to a concentra-
tion of 6 x 107 nucleated cells/ml and were infused into recipient animals by intravenous
injection into the dorsal tail vein on day 0. The total volume injected was 1 ml.
Induction and Adoptive Transfer.
￿
To study the requirements for the induction of SGVHD,
rats were treated with immunoablative therapy, infused with bone marrow, and subcutane-
ously injected with CsA for 30 d. To analyze the requirements for the transfer of disease,
secondary recipients were either irradiated or treated with immunoablative therapy, and bone
marrow was reconstituted and infused with effector splenocytes from autoimmune donors
on day 0 unless otherwise indicated. Effector splenocytes were harvested from animals with
early onset ofSGVHD 10-14 d after CsA therapy after lethal irradiation and syngeneic marrow
transplantation.
Antibiotics
Rats received medicated drinking water supplemented with bactrim, neomycin, and poly-
mixin B as previously described (8).
Cyclosporine
CsA was the generous gift of Sandoz, Ltd., Basel, Switzerland. The powdered CsA was
dissolved in 95% ethanol and added to a 57o emulphor solution in deionized H2O. Rats were
weighed daily and received 1 ml/100 g/day subcutaneously from the day ofmarrow infusion
for 30 consecutive days. The total dose ofCsA per day per rat was 15 mg/kg. Control animals
received the identical quantities of the drug diluent (ethanol, 5% emulphor, H2O) without
CsA.Assessment of GVHD
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Rats were examined daily for signs of clinical GVHD such as red ears, alopecia, derma-
titis, or diarrhea. Ear and skin biopsies were taken at frequent intervals. Previously described
criteria were used for the histological documentation of acute and chronic GVHD (13, 14).
Monoclonal Antibodies
Murine mAbs directed against rat lymphocyte determinants were purchased from Serotec
(Bioproducts for Science, Inc., Indianapolis, IN). The specific mAb from ascites fluid used
in our studies consisted of W3/13 (pan-specific for rat T lymphocytes) and OX19 (pan-specific
for rat T lymphocytes).
Cell Separation
Spleen cells from normal animals were fractionated over nylon wool (Fenwall Laborato-
ries, Deerfield, IL) to enrich for T cells as previously described (15). The nonadherent popu-
lation was >85% OX19' by FAGS analysis.
Panning.
￿
Nylon wool-nonadherent spleen cells from normal animals were depleted of T
lymphocytes by panning, as previously described (16). Briefly, 107 lymphocytes, incubated
for 1 h at 4°C with 0.2 ml of a 1:10 dilution of OX19 in PBS, were placed in petri dishes
coated with affinity-purified goat anti-mouse IgG (Tago Inc., Burlingame, CA), the plates
were lightly centrifuged and incubated for 1 h at 4°C. The nonadherent fraction was aspi-
rated and reincubated with newlycoated petri dishes for a second panning. The nonadherent
fraction was again aspirated and the plates were carefully rinsed with a 0.2 % BSA-PBS solu-
tion. The OX19-depleted population was analyzed with a directly FITC-conjugated W3/13.
Immunomagnetic Separation.
￿
Nylon wool-nonadherent spleen cells from normal animals were
separated into lymphocyte subsets by immunomagnetic separation using immunomagnetic
beads coated commercially with covalently bound, affinity purified (Fc specific) sheep poly-
clonal immunoglobulin against mouse IgG1 subclass (Dynabeads, Dynal Inc., Great Neck,
NY) as previously described (17). Briefly, 5 x 107 cells were incubated with saturating con-
centrations ofprimary antibody for 1 h at 4°C on a hematology mixer (Fisher Scientific Co.,
Pittsburgh, PA). At the end of the incubation the supernatant was removed and the cells
were thoroughlywashed with PBS and 0.5% BSA three times. The cells were then incubated
with the microspheres (one cell/five beads) for 30 min at 4°C on a hematology mixer. To
remove the unbound cells from the suspension, the tube was held near a Dynal Magnetic
Particle Concentrator for a few minutes, the suspension was removed with a Pasteur pipette,
and the positively selected cells, complexed to the microspheres, were immobilized by the
magnetic field.
FACS Analysis.
￿
After each type of cell separation listed above, the depleted populations
were stained with an appropriate mAb and the single label immunofluorescence was ana-
lyzed on a Hewlett-Packard Co. (Palo Alto, CA) FACSCAN analytical scanner. The nega-
tively selected populations depleted with OX 19 either by panning or immunomagnetic sepa-
ration resulted in <15% W3/13' by immunofluorescence.
Results
The Role ofIrradiation in the Induction andAdoptive Transfer ofSGVHD.
￿
The current
studies were designed to identify the specific levels of irradiation necessary for the
manifestation of SGVHD by direct primary induction or by adoptive transfer.
For the induction studies, Lewis rats were subjected to graded dosesof whole body
irradiation followed by infusion of syngeneic marrow (6 x 107 nucleated cells) and
treatment with CsA for 30 d. The incidence of SGVHD was assessed for each dose
ofradiation. Lethal total body irradiation of 1,050 rad on the day before bone marrow
reconstitution and the start ofCsA therapy correlated with a 100% incidence ofclinical
SGVHD as indicated in Fig. 1 . At a sublethal dose of 750 rad, one-third of the rats
tested demonstrated a severe clinical and histologic SGVHD. Lower doses ofirradi-1034
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FIGURE 1 . The clinical inci-
dence ofSGVHD after different
doses of radiation . The recipi-
ents, receiving different doses of
radiation, either were trans-
fused with 50 x 10 6 splenocytes
from autoimmune donors (solid
bars) or were treated with CsA
in order to induce SGVHD
(hatchedbars). The average num-
ber ofrats studiedin each group
was greater than five .
ation tested were ineffective in allowing the induction of SGVHD . At all levels of
radiation control animals treated with mock diluent post marrow reconstitution
demonstrated no evidence of disease as did animals treated with CsA that did not
receive any irradiation .
For the adoptive transfer studies, Lewis rats were prepared with graded doses of
radiation followed by infusion of splenocytes from animals with active SGVHD to-
gether with normal marrow. Both lethal and sublethal doses of radiation elicited
a high incidence of severe SGVHD upon the infusion of effector splenocytes (Fig .
1) . At 500 rad, one of seven rats demonstrated clinical SGVHD, and three other
animals exhibited histologic SGVHD. The lowest dose of irradiation, 300 rad, was
ineffective in abolishing the resistance to the adoptive transfer of disease . Similarly,
infusion of effector splenocytes into nonirradiated animals did not transfer the dis-
ease (data not shown) . Decreasing doses of radiation correlated with a reduction
in the histologic grade, hence severity, of acuteGVHD. Secondary recipients treated
with 1,050 or 750 rad demonstrated predominately a grade three acute SGVHD
histologically . The animal with clinical SGVHD treated with 500 rad demonstrated
a histologic grade 2.
TheRole ofOther Preparative Regimens in the Induction versus Adoptive Transfer ofAutoreac-
tivity. As indicated above, irradiation is an integral component in both generating
autoimmune precursors and abolishing host resistance to adoptive transfer; other
preparative regimens were thenext tools in which to distinguishthe individual char-
acteristics inherent in each system using an experimental design similar to that de-
scribed above for defining the radiation sensitivity . CY at all doses, 200, 100, 50,
and 25 mg/kg, combined with a30-d subsequent regimen ofCsA, was an ineffective
preparative regimen fortheprimary induction ofSGVHD, asshown in Fig . 2. However
CY at a dose of 200 or 100 mg/kg given on the day before adoptive transfer resulted
in amaximum incidence ofacuteSGVHD clinically detectable by day 10 . Theseverity
as noted pathologically was a grade 2 acute SGVHD at a dose of 200 mg/kg and
dropped to a grade 1 acute SGVHD at 100 mg/kg . These data suggest that the
abolishing of host resistance to adoptive transfer of SGVHD is dependent on the
dose of CY used .FISCHER ET AL .
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Table I demonstrates that a busulfan preparative regimen of 30 mg/kg on day
-2 before bone marrow rescue and subsequent CsA therapy did not result in the
induction ofSGVHD : a low incidence ofSGVHD (one of eight rats) didoccur with
concomitant busulfan and CY therapy, but did so much later (day 28) compared
with that observed (day 10-14) when irradiation (1,050 rad) was used as the ablative
therapy. In the case of adoptively transferring SGVHD, one of seven rats treated
with busulfan treatment alone had a clinical picture of acute SGVHD, which also
occurred late . These studies suggest that the nature of the autoregulatory system
is radiosensitive, CY sensitive, and relatively busulfan resistant .
Previous studies have shown that thymic irradiation was necessary for the induc-
tion ofSGVHD (8, 10) . We explored whether thymic irradiation was necessary for
the adoptive transfer of disease . The data in Table I show that thymic irradiation
with a collimated beam focused on the thymus followed by autologous reconstitu-
tion and adoptive transfer of effector splenocytes allowed for the successful transfer
ofSGVHDin five ofeight animals. Lowerhemibody irradiation did not allow transfer
TABLE I
The Influence of Other Preparative Regimens on the Induction or Adoptive
Transfer of Syngeneic GVHD
FIGURE 2 . The clinical inci-
dence ofsyngeneicGVHD after
CY therapy . The recipients, re-
ceiving various doses ofCY, ei-
ther were transfused with 5 x
10 6 effector splenocytes (solid
bars) or were treated with CsA
therapy to induce SGVHD
(hatched bars). The average num-
ber ofrats studied in each group
was greater than five .
The fraction ofrecipients with clinical GVHD after either inductive therapy or
adoptive transfer. The recipients were treated with various preparative regimens .
GroupsA and B were reconstituted with 50 x 106 bone marrow cells . Groups
C andD underwent autologous reconstitution . The rats in the adoptive transfer
study received 50 x 106 splenocytes from autoimmune donors .
Group
Incidence of
Induction
syngeneic GVHD
Adoptive transfer
A Busulfan (30 mg/kg) 0/8 1/7
B Busulfan (30 mg/kg) and
cytoxan (200 mg/kg) 1/8 ND
C Upper hemibody irradiation ND 5/8
D Lower hemibody irradiation ND 0/81036
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of SGVHD. These data suggest that thymic irradiation is important for the aboli-
tion of host resistance mechanisms specific to this syndrome.
The Characterization oftheAutoregulatory Pbpulation by Adoptive Cotransfer Studies.
￿
The
studies above provideevidence that thereis a host resistance or autoregulatory system
preventing the adoptive transfer ofSGVHD. To document andcharacterize the au-
toregulatory cell, a series ofadoptive cotransfer studieswere performed. Two different
dosesof effector splenocytes from rats with SGVHDwere compared sincethe poten-
cies of a given effector population can not be predicted. The variables of time after
CsA withdrawal, the timing and stage of disease manifestation, or inherent differ-
ences in the capability of a population to undergo clonal expansion can explain the
varying potencies of effector cells. Both doses of effector splenocytes (15 and 30 x
106) were capable of establishing clinical and grade 2 histologic SGVHD in irradi-
ated secondaryrecipients (Table II). The transfer of spleen cells from reconstituted
non-CsA-treated rats did not mediate disease (data not shown). The cotransfer of
30 x 106 unfractionated lymphocytes from a normal rat prevented the establish-
ment of SGVHD in recipients receiving 15 x 106 effector lymphocytes and reduced
the clinical incidence of SGVHD in those receiving an equivalent dose of effector
splenocytes. In both cases thecotransfer of normal unfractionated splenocytes down-
regulated the histologic severity of SGVHD from a grade 2 to a grade of 1 of the
animals developing disease. If the cotransferred splenocytes were first fractionated
over nylon wool and shown to be >85% OX19+ by FAGS analysis, then 30 x 106
nylon wool-nonadherent splenocytes were as or more effective than unfractionated
splenocytes in reducing the incidenceof SGVHD upon the cotransfer ofan equiva-
lent number of effector splenocytes (Table II, group B) . The cotransfer of 30 x 106
nylon wool-nonadherent splenocytes and 15 x 106 effector splenocytes resulted in
TABLE II
The Adoptive Transfer of Effector Splenocytes with Splenocytes from Normal Rats
The cotransfer of effector splenocytes from autoimmune donors with fractionated and unfrac-
tionated splenocytes from a normal animal. Syngeneic marrow (60 x 106 cells) and effector
splenocytes (15 x 106 cells in A, 30 x 106 cells in B, and 50 x 106 cells in C) were transfused
into lethally irradiated recipients. InA and B, the secondary recipients received either no spleno-
cytes (-), or 30 x 106 unfractionated splenocytes, or 30 x 106 nylon wool-nonadherent
(NWNA) splenocytes from a normal animal. In C, the secondary recipients received either no
splenocytes, 50 x106 NWNA splenocytes, or 50 x 106 OX19-depleted NWNA splenocytes from
a normal rat.
Group
Splenocytes
SGVHD rat Normal rat
Fraction with
clinical GVHD
Histologic grade
of positive animals
x 106
A 15 - 5/7 II
15 Unfractionated 1/4 I
15 NWNA 0/8 0
B 30 - 7/7 II
30 Unfractionated 2/4 I
30 NWNA 1/4 I
C 50 - 3/3 II
50 NWNA 0/3 0
50 T cell depleted 5/5 IIPercent GVHD
100 ~-
60
20
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FIGURE 3.
￿
The incidenceofGVHD afterdelaying the initiation ofCsAtherapyaftertransplan-
tation.CsAtherapywasinitiatedon days 0(the dayoftransplant), 4, 7, and 14 aftertransplanta-
tion andcompared with initiating CsAtherapy without irradiation andtransplantation (PreTx).
The average number of rats per group was four.
no evidence ofGVHD (Table 11, group A) clinically orhistologically. Hence nylon
wool-nonadherent splenocytesappearedto be moreeffective insuppressingthetransfer
of disease than unfractionated splenocytes. Table II, group C, demonstrates that
the depletion of nylon wool-nonadherent splenocytes of OX19+ lymphocytes re-
movedthe autoregulatory effect present in normal splenocytes. Depletion protocols
bothbypanningand immunomagnetic separation resulted inaT cell-depleted popu-
lation with <20% staining with W3/13 (another pan-specific T cell marker thathas
some crossreactivitywith othercell types, i.e., polymorphs and stem cells [18]). The
transfer of 50 x 106 effector splenocytes elicited SGVHD in lethally irradiated sec-
ondary recipients: only the cotransfer of nylon wool-adherent splenocytes and not
the OX19-depleted population prevented the transfer of disease.
The Critical Period after Transplantation to Initiate CsA Therapy or the Adoptive Transfer
of Effector Splenocytes. The present study correlated the time of initiation of daily
CsA therapy after irradiation and bone marrow transplantation with the incidence
ofclinical andpathologically evident SGVHD. Adelayin theinitiation ofCsAtherapy
for 4-5d afterbone marrowtransplantation still resulted in the maximum incidence
ofSGVHD. IfCsA treatment wasdelayed until 7 d after transplantation, then only
30% of the rats developed SGVHD (Fig. 3).
Likewise, the time of infusion ofunfractionated effector splenocytes after lethal
irradiation ofsecondary recipients is critical to elicit acomplete transferofSGVHD
(Fig. 4). Ifeffector splenocyteswere transferred betweenday 0to4 aftertransplanta-
tion, then all rats manifested severe GVHD usually between 14 to 21 d later. By
day 7 after bone marrow transplantation, evidenceofa resistance mechanismisclear,
since 30% ofthe secondaryrecipients were nowresistant to thetransferofSGVHD.
Rats 14 d after transplantation were comparable to pretransplant rats; both were
absolutely refractory to the adoptive transfer of SGVHD.1038
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FIGURE 4.
￿
Theincidenceof SGVHD in lethally irradiated recipients. The secondary recipients
received 50 x 106 effector splenocytes prior to irradiation and transplantation (PreTx), or on
days 0, 4, 7 after irradiation and transplantation. The number of animals per group was four.
Discussion
The pathogenesis of SGVHD remains unclear. This autoaggression syndrome
represents a disruption in the normal regeneration ofa competent T cell repertoire
concurrent with self-tolerance after syngeneic bone marrow transplantation. One
oftheprimarymechanisms thought toaccount for SGVHDhasbeenthe generation
ofautoreactive cells recognizing self MHC antigens. Recent studies by Hess et al.
(12) have shown that the development ofSGVHD is associated with the induction
ofcytotoxic lymphocytes directed against apublic epitope ofclass II antigens. The
generation of "self" class II MHC antigenreactivecellsappearsto be directly related
to the effect of CsA on thymic function (11, 19, 20). Previous studies have shown
that CsA therapy and irradiation abolishes thymic medullary epithelial cells and
causes a reduction inclass II antigen expression (11, 19). These irreversible changes
are thought to prevent the normal mechanisms ofeliminating self-reactive clones.
Thymic epithelial cells and dendritic cells are known to be crucial in the education
ofself-MHC restriction andhence a microinductive environment for self-tolerance.
Recent studies have shown that CsA can inhibit the intrathymic events inherent in
clonal deletion, by potentially interfering with the Tcell receptor signal transduc-
tion or reducing class II expression (20). Nevertheless, even in the normal animal,
the presence ofautoreactive cells in the periphery is evidence ofincomplete clonal
deletion and implies controlby a peripheral regulatory mechanism (21). Therefore,
this peripheral mechanism must be eliminated to allow development of SGVHD.
In this study, the disparity between drug and radiation sensitivities exemplifies
two distinct underlying mechanisms, the generation of autoreactive cells and the
elimination of a host resistance mechanism. First, the radiosensitivity of the host
resistance mechanism is more sensitive than that ofthe inductive mechanism since
low doses ofirradiation allowed the adoptive transfer ofSGVHD but were unable
to permit theinduction ofSGVHD. Secondly, CY in adose-dependent fashion elim-
inated host resistance mechanisms but was unable to trigger the events essential forFISCHER ET AL.
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inductionofSGVHD. AlthoughCYcan inhibit peripheral regulatory mechanisms,
itwas surprisingly ineffectivein inducingSGVHD, revealingapossible intrinsicdiffer-
encebetween the roles ofCY and irradiation in alteringintrathymic events essential
fordiseasemanifestation. Itcanalsobe inferred thattheeliminationofan autoregula-
tory mechanism is insufficient by itself for the induction of SGVHD.
The present studies also suggest that resistance to adoptive transfer is a distinct
mechanism controllingthe developmentofSGVHD and isconsistentwith previous
studies. While normal nonirradiated rodents upon CsA therapy alone fail to mani-
fest any clinical signs of SGVHD, lymphoid cells from these donors inflict severe
autoaggression whentransferredto asecondary, irradiated recipient (12), implicating
aputative autoregulatory mechanism in controllingthe induction ofSGVHD. Fur-
therevidence ofan autoregulatorysystem isdemonstrated in the adoptive cotransfer
studies. Nylon wool-nonadherent Tcells expressing the OX19 determinant, present
on mature T lymphocytes, abrogated the transfer and establishment of SGVHD.
For every effector splenocyte transferred twounfractionated splenocytes from normal
donors were required forinhibition. Thisevidence demonstrates thatan autoregulatory
population is present inanormal animal andthat theratio between autosuppressors
to autoreactive cells is critical intheinhibition ofSGVHD, consistent withthe findings
of Sorokin et al. (10). Current studies are focused on the analysis of the actual T
cell subsets involved.
The delay ofCsA administration demonstrated that the initial 4-5 d after trans-
plantation is a critical window in which the initiation of CsA therapy is essential
in altering the thymic microinductive environment influencing the generation of
self-reactive cells in aclass II deficient environment. On the otherhand, the ineffec-
tiveness ofeffector splenocytesthat are transferred 1 wk after transplantation to mediate
SGVHDdemonstrates thattheautoregulatory armisapparently reconstitutedwithin
the first week after bone marrow transplantation. Hence lethal irradiation may be
critical for abolishing mature suppressor mechanisms present either in the thymus
and/or inthe periphery. Therefore, the effect ofCsA therapy maynot only be related
to the generation ofthe effector cell but may also berelatedtopreventing the recon-
stitution ofan autoregulatory mechanism, while allowing theexpansion ofself-reactive
cells.
The synthesis of this data suggests that there are distinct mechanisms involved
in disruption ofthe immunologic balance between autoaggression and autoregula-
tory suppression leadingto SGVHD. Onefacet involves the generation ofautoreac-
tive cells; the other involves the disruption of peripherally active tolerance main-
taining mechanisms. The generation ofself-reactive cells cannot singularly explain
SGVHD. In fact autoreactive cells capable ofmediating SGVHD can be detected
inanimalstreated with CsA withoutdemonstratingclinicaldisease whenadoptively
transferred into a lethally irradiated recipients (11). The prevention ofintrathymic
clonal deletion and theperturbationofthe autoregulatory cell regeneration in arecon-
stituting animal may be the determining factors in disease manifestation. Abolish-
ment ofautoregulation can be the putative event that creates a permissive environ-
ment for the expansion of autoreactive cells and the subsequent generation of
autoimmune disease. Previous studies suggesting that defects in Tcell subsets have
been associated withautoimmune disease inexperimental animalssupportthisconcept
(18, 22).1040￿
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Summary
These studies furtherdelineatethe requirements forthe establishmentand transfer
ofSGVHD. We show that (a)two mechanisms distinguishable byradiation and drug
sensitivities exist, (b) lethal irradiation correlates with a 100% incidence in the in-
duction of SGVHD, whereas (c) both sublethal or lethal irradiation and cytoxan
therapy are effective in ablating the host autoregulatory system in order to transfer
autoreactivity, (d) unfractionated as well as nylonwool-nonadherent splenocytes effec-
tively inhibit the transfer ofautoimmunity, and (e) OX19 depletion ofthat popula-
tion, however, destroys the autoregulatory effect present in normal splenocytes. To
demonstrate complete inhibition ofimmune reactivity, twice thenumberofunfrac-
tionated splenocytes from normal animals was required for every splenocyte from
autoimmune donors. Last, the infusion ofeffector splenocytes on 4, 7, and 14 d after
transplantationcorrelates to adecreasefrom 100%, 70to 0% incidence ofSGVHD,
thus emulating the incidence obtained in a pretransplant rat within 2 wk. These
findings further clarify the immunobiological complexity of SGVHD and suggest
that since autoregulatory cells already exist in normal animals that CSA-induced
autoimmunity is a reflection ofnot an induced reactivity specific to one therapeutic
reagent but the uncoupling ofnormal immunologic mechanisms essential in con-
trolling autoimmunity.
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